EXACT Therapeutics AS: Primary insider notification
EXACT Therapeutics AS (EXTX) · publisert 2024-12-11 17:47 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Investinor Direkte AS 2 a) Position/status The notification concerns a close associate of a primary insider, board member, Ann-Tove Kongsnes. nærstående | The notification concerns a close associate of a primary insider, board member, Ann-Tove Kongsnes. | other | 3 096 083 | 0 NOK | 2024-12-11 | – | Outside of trading venue Notification of transactions by Primary Insiders and Close Associates | rules · til gjennomgang |
| Helene Sundt AS 2 a) Position/status The notification concerns a close associate of a primary insider, board member, Leiv Askvig. nærstående | The notification concerns a close associate of a primary insider, board member, Leiv Askvig. | other | 803 955 | 0 NOK | 2024-12-11 | – | Outside of trading venue Notification of transactions by Primary Insiders and Close Associates | rules · til gjennomgang |
| PAACS Invest AS 2 a) Position/status The notification concerns a close associate of a primary insider, board member, Masha Paule Nathalie Legris Strømme. nærstående | The notification concerns a close associate of a primary insider, board member, Masha Paule Nathalie Legris Strømme. | other | 2 699 842 | 0 NOK | 2024-12-11 | – | Outside of trading venue | rules · til gjennomgang |
Vedlegg
- 241211 EXACT-Tx Notification of transactions by Primary Insiders.pdf (tekst hentet ut)
Meldingstekst
11 December 2024: Reference is made to the primary insider notification published on 3 December 2024 by EXACT Therapeutics AS ("EXACT-Tx" or the "Company") regarding the share lending agreement entered into with, among others, Investinor Direkte AS, PAACS Invest AS and Helene Sundt AS, which are close associates of primary insiders, pursuant to which they granted Carnegie AS an option to borrow ordinary shares to facilitate settlement in the Company's private placement. The new shares have today been registered in the Norwegian Register of Business Enterprises and Carnegie AS has re-delivered the shares to, among others, Investinor Direkte AS, PAACS Invest AS and Helene Sundt AS.
Please see the attached notification form for further information.
This information is subject to the disclosure requirements in section 5-12 of the Norwegian Securities Trading Act.
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
About EXACT-Tx:
EXACT-Tx is a clinical-stage precision medicine company utilizing the power of ultrasound and microbubbles to enable targeted drug delivery in oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy) and brain diseases. www.exact-tx.com